Gidi Littwin’s new AI startup, Hemispheric, makes diagnostic brain scans for conditions like depression, PTSD, and Parkinson’s. He wants the technology to be as cheap and easy as a blood test.
Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help underserved populations and combat rare diseases.
The biodegradable material can help improve healing after surgery—or an avocado-related accident.
Coherence Neuro has started testing a brain-computer interface that could one day use electrical stimulation to prevent tumors from growing.
It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.
Leading AI labs, executives, and scientists are sending a letter to lawmakers urging them to improve tracking of synthetic DNA sequences that could be used for bioweapons.
Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn’t likely coming any time soon.
Researchers have developed three new antibiotics from scorpion venom and habanero peppers to combat tuberculosis and other drug-resistant pathogens.
Bootstrap Bio and Manhattan Genomics, which were pursuing human embryo editing to prevent serious disease, have shut down.
Paterna Biosciences says it has determined the set of instructions needed to turn sperm-making stem cells into “normal, mature” sperm.